Stainless , As I see it , a lot is riding on the upcomming trial results . Due out this quarter . I would not be surprised if the cancer trials were late because I think they are tracking the secondary immune system response against the tumours , and there could be a good survival rate . If that occurs in a phase 1 safety trial it is amazing . They said months ago they had already met their safety trial end points . As the clinical trial data is revealed , if it is good , it will be hard to hold this stock back IMHO.
The psoriasis trial could also lead them into another lucrative market . Due out before the cancer trial .
There are the results of further lab work with mice by the TIG at UWA on the Hybridon DNA drug and Coramsine combination , perhaps leading to a trial announcement . The research is on mesothelioma and melanoma , both fast track /accelerated approval candidates .I think that is due March/April .
Once the ADRs start trading in the USA it may have a positive effect on the price . Check this link to an emerging USA glyco co , with no candidates yet in trials . Years behind Solbec . Check out the market cap http://finance.yahoo.com/q/bc?s=ntec&t=&c=
Yes stainless , I think the price will go up some .
Cheers
- Forums
- ASX - By Stock
- ...skint...
SBP
solbec pharmaceuticals limited
Stainless , As I see it , a lot is riding on the upcomming trial...
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
Previous Video
Next Video
SPONSORED BY The Market Online